Baxter
BAX
#1140
Rank
ยฃ12.93 B
Marketcap
ยฃ25.32
Share price
0.82%
Change (1 day)
-11.31%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : ยฃ14.74 Billion

According to Baxter's latest financial reports the company's total liabilities are ยฃ14.74 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Baxter - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ15.54 B-16%
2022-12-31ยฃ18.50 B2.39%
2021-12-31ยฃ18.07 B118.18%
2020-12-31ยฃ8.28 B5.67%
2019-12-31ยฃ7.84 B26.71%
2018-12-31ยฃ6.18 B4.59%
2017-12-31ยฃ5.91 B0.46%
2016-12-31ยฃ5.88 B-27.86%
2015-12-31ยฃ8.16 B-29.32%
2014-12-31ยฃ11.54 B13.82%
2013-12-31ยฃ10.14 B22.29%
2012-12-31ยฃ8.29 B5.33%
2011-12-31ยฃ7.87 B13.73%
2010-12-31ยฃ6.92 B12.83%
2009-12-31ยฃ6.13 B-1.95%
2008-12-31ยฃ6.26 B48.46%
2007-12-31ยฃ4.21 B-1.82%
2006-12-31ยฃ4.29 B-12.11%
2005-12-31ยฃ4.88 B-10.14%
2004-12-31ยฃ5.43 B-6.74%
2003-12-31ยฃ5.83 B-1.96%
2002-12-31ยฃ5.94 B30.97%
2001-12-31ยฃ4.54 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ36.71 B 149.06%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ18.76 B 27.31%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ13.56 B-7.97%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ23.54 B 59.71%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.31 B-91.05%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ40.62 B 175.56%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.33 B-77.39%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.95 B 123.55%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ1.78 B-87.91%๐Ÿ‡บ๐Ÿ‡ธ USA